597591 Agitation in a Microcarrier-Based Spinner Flask Bioreactor Modulates Homeostasis of Human Mesenchymal Stem Cells

Tuesday, November 17, 2020
Food, Pharmaceutical & Bioengineering Division (15) (Poster Gallery)
Richard Jeske1, Shaq Lewis2, Ang-Chen Tsai3, Kevin Sanders4, Xuegang Yuan5 and Yan Li3, (1)Chemical and Biomedical Engineering, The Florida State University, Tallahassee, FL, (2)Meharry Medical College, Nashville, TN, (3)Chemical and Biomedical Engineering, Florida State University, Tallahassee, FL, (4)FSU, Tallahassee, FL, (5)Chemical & Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL

Human Mesenchymal Stem Cells (hMSCs) are well known in cell therapy due to their secretion of trophic factors, multipotent differentiation potential, and ability for self-renewal. As a result, the number of clinical trials has been steadily increasing over the last decade highlighting the need for in vitro systems capable of producing large quantities of cells to meet growing demands. However, hMSCs are highly sensitive to microenvironment conditions, including shear stress caused by dynamic bioreactor systems, and can lead to alteration of cellular homeostasis. In this study, we demonstrate a 3-fold expansion of hMSCs within a 125 mL spinner flask bioreactor system. Furthermore, we show culturing in this dynamic environment (compared to conventional 2D planar culture) results in hMSCs exhibiting higher total levels of reactive oxidative species (ROS), as well as known ROS regulator Sirtuin-3, having implications on the nicotinamide adenine dinucleotide (NAD+) metabolic pathway and metabolic homeostasis. In addition, added stress from culturing in this dynamic microenvironment increased Prostaglandin E2 (PGE2) secretion as well as reduced the potential for Indoleamine-pyrrole 2,3-dioxygenase (IDO) secretion upon stimulus with interferon gamma (IFNγ). The results of this study have implications on engineering strategies for scalable production of hMSCs utilized in clinical trials and biomanufacturing.

Extended Abstract: File Not Uploaded
See more of this Session: Poster Session: Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division